James Hambro & Partners Nuvasive Inc Call Options Transaction History
James Hambro & Partners
- $2.25 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NUVA
# of Institutions
9Shares Held
116KCall Options Held
0Put Options Held
0-
Rothschild & CO Asset Management Us Inc. New York, NY66KShares$00.04% of portfolio
-
Walthausen & Co., LLC Malta, NY25.3KShares$00.92% of portfolio
-
Eaton Vance Management Boston, MA17.2KShares$00.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V86.27KShares$00.0% of portfolio
-
First Capital Advisors Group, Llc. Little Silver, NJ487Shares$00.01% of portfolio
About NUVASIVE INC
- Ticker NUVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 52,061,000
- Description
- NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...